INTRODUCTION
Dyslipidaemia is one of the many well-established risk factors for cardiovascular diseases. High total cholesterol was ranked the second most prevalent cardiovascular risk factor among adult Singaporeans aged 18-69 years in the year 2010, (1) with a prevalence of 17.4%, higher than diabetes mellitus, obesity and daily smoking. (2) It is a modifiable cardiovascular risk factor with potential for the prevention of cardiovascular events. Indeed, the report from the National Cholesterol Education Programme showed that the decline in death rates from coronary artery disease was likely due to the improvement in modifiable risk factors in the general population.
The general public's perception and attitude toward the management of cholesterol and other risk factors are critical in ensuring effective translation of evidence-based medicine into everyday practice. However, there is limited data on the general public's perception and awareness of this issue in Singapore.
Anecdotally, as physicians, we often encounter concerns about the potential side effects of cholesterol treatment. Hence, this study was conducted to examine the level of public awareness and to identify areas of misconception with regard to cholesterol management.
METHODS
The study was commissioned by the Singapore Heart Foundation, which engaged a professional market survey company, Research
Plus Pte Ltd, Singapore, to conduct a nationwide questionnaire survey. This study was supported by a grant from AstraZeneca Singapore Pte Ltd. The selection of subjects for the main sample involved quota sampling, followed by random sampling at two levels. Firstly, quota sampling across all five community development council districts was performed to ensure that the sample was representative of the Singapore population. Then, random sampling of households from each selected cluster was carried out. Among the residents of the household that were present at the time of the survey, the respondents were randomly selected using the Kisch Grid method. Door to door interviews were conducted from June 29, 2009 to August 3, 2009, on weekends from 10 am to 10 pm and on weekdays from 6 pm to 10 pm.
The total sample consisted of the main sample and a booster sample of respondents with high cholesterol levels. The main sample comprised 313 respondents, of which 17% had high cholesterol levels, while the booster sample comprised 52 respondents with high cholesterol levels, to ensure adequate sample size in this group of patients. In computing and presenting Public perceptions, knowledge and awareness of cholesterol management in Singapore: a prospective pilot study INTRODUCTION Hyperlipidaemia is a major risk factor for coronary artery disease (CAD). Its effective treatment has been shown to reduce the incidence of cardiovascular events, both in secondary and primary prevention. An essential component of risk factor management at the community level is public awareness and knowledge of treatment benefits. However, this data is limited in Singapore.
METHODS A cross-sectional survey questionnaire of public perception and knowledge on cholesterol treatment among adult Singaporeans aged 30-69 years was commissioned by the Singapore Heart Foundation and conducted by a professional market survey company. Regional quota sampling was performed to ensure that the sample was representative of the Singapore population. This was followed by random sampling of households and respondents. CONClUSION There are gaps in the level of public awareness and understanding of cholesterol treatment in Singapore.
RESUlTS
Common misconceptions should be addressed, as they could potentially impair effective management or treatment compliance.
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the results of the overall total study population, we corrected for the increased sampling of the high cholesterol group by weighting the results to match the distribution of the proportion of high cholesterol patients in the overall population. The eligibility criteria included adults aged 30-69 years who were either Singapore citizens or permanent residents. Respondents from market research, public relations, the media, pharmaceutical, medical or healthcare industry were excluded so as to avoid conflict of interest and potential bias.
RESUlTS
A total of 365 subjects were interviewed, among whom 104
were reported to have dyslipidaemia that was diagnosed within the last five years. The demographic profile of the respondents involved in this study is as stated in Table I Unhealthy food or poor diet was identified as the top cause of high cholesterol. Some also attributed it to a lack of exercise and hereditary causes (Table II) . Heart disease and stroke were seen to be related to high cholesterol level. In addition, high blood pressure was perceived to be a result or consequence of high cholesterol, albeit untrue (Table II) . Only 11.0% of the total respondents knew their actual cholesterol levels, and this number was slightly higher among those with dyslipidaemia (17.3%).
The respondents were asked to identify the statement(s) that they agreed with from a list (Table III) 
DISCUSSION
Despite the long-established evidence regarding the importance, safety and effectiveness of cholesterol treatment (4) (5) (6) in the reduction of cardiovascular morbidity and mortality, our study revealed gaps in public awareness and understanding of hyperlipidaemia in Singapore. A considerable proportion of the general public (86.0%) did not know their current cholesterol levels. This figure is higher than an earlier national survey by the American Heart Association, which reported that 50.8% of adults aged 40 years and older did not know their own cholesterol level.
In our study, heart disease and stroke were perceived to be the top two consequences of high cholesterol. However, one fifth of the respondents associated cholesterol with blood pressure. Similar misconceptions were also reported in another study, where some participants assumed that high cholesterol levels and high blood pressure cause each other and that the symptoms of the two conditions are the same. A third of the respondents felt that it was healthier and safer to take herbal medicine than prescribed Western medications. In Singapore, many people opt to seek traditional or herbal therapies to lower cholesterol level. Some of the reasons cited include personal preference, cultural beliefs, easy accessibility as these are largely over-the-counter items, or the patients could have experienced side effects from Western medications, e.g. myalgias.
However, the long-term effects of herbal medication have not been extensively studied.
The majority of our respondents (87.8%) felt that diet and exercise are equally effective at lowering cholesterol as medication. On the contrary, medication is usually more effective at lowering cholesterol than lifestyle changes such as diet and exercise. (9) However, the best result is achieved by combining (95% CI 2.96-6.17, p < 0.01) for those with three lifestyle changes plus medication. (9) In addition, one common belief was that statins could be stopped once a target level of lipids was achieved, yet many also believed that statins could not be stopped once started.
More than half of the respondents believed that long-term use of statin would lead to liver and kidney damage, while 38% of them associated its use with increased cancer risk. Contrary to these beliefs, systemic reviews on the adverse effects of statins showed that in randomised trials, there were fewer reports of hepatobiliary disorders and no excess of renal disease or proteinuria in patients allocated to statin compared to placebo.
The notification rate of liver failure was one per million personyears of statin use. (10) In addition, a report by the National Lipid
Association revealed that cases of acute liver failure and acute or chronic kidney disease, after correcting for underreporting, were similar to their baseline rates in the general population. Hence, their link with statins could not be convincingly established. (11) Regarding concerns for cancer risk, a previous large randomised study had found that there were no significant differences in the incidence of various cancers in patients receiving simvastatin compared to placebo during the follow-up period of 11 years. (6) Paradoxically, a higher proportion of tertiary educated respondents appeared to believe that statins were associated with risks of cancer or liver disease, although this was not statistically significant in our small sample. We might speculate about the influence of misinformation that is widely available on the Internet, although this is conjectural. Nevertheless, previous studies have shown that the level of education has a significant impact on the public's knowledge and awareness on health matters. A recent study on the knowledge gaps and misconceptions concerning coronary heart disease (CHD) among South Asians in the United States found that individuals with lower education were associated with less knowledge, as well as the belief that CHD is not preventable. (12) Our study has several limitations. The small sample size limits the generalisability of our findings. In addition, the validity and reliability of the questionnaire have not been tested or standardised from other studies. Due to the small sample size, we could not study the correlation between the characteristics of the respondents, for instance socioeconomic status, educational level and ethnicity, with their responses. Future study should focus on identifying the predictors of the public's responses and tailoring public education strategies effectively based on the profile of the target audiences.
In conclusion, there are gaps in public awareness and understanding of cholesterol management in Singapore. Our study offers insights into the magnitude of the problem and highlights the need for more effective measures to increase awareness on cardiovascular risk factor control. The results of this study also remind healthcare providers that listening to our patients and understanding their ideas, concerns and expectations are some of the keys to treatment success.
